Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Evaluation of the basal ganglia in neurofibromatosis type 1.

Nicita F, Di Biasi C, Sollaku S, Cecchini S, Salpietro V, Pittalis A, Papetti L, Ursitti F, Ulgiati F, Zicari AM, Gualdi GF, Properzi E, Duse M, Ruggieri M, Spalice A.

Childs Nerv Syst. 2014 Feb;30(2):319-25. doi: 10.1007/s00381-013-2236-z. Epub 2013 Jul 27.

PMID:
23892392
2.

Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.

Billiet T, Mädler B, D'Arco F, Peeters R, Deprez S, Plasschaert E, Leemans A, Zhang H, den Bergh BV, Vandenbulcke M, Legius E, Sunaert S, Emsell L.

Neuroimage Clin. 2014 Apr 13;4:649-58. doi: 10.1016/j.nicl.2014.04.005. eCollection 2014.

3.

Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.

Ferraz-Filho JR, José da Rocha A, Muniz MP, Souza AS, Goloni-Bertollo EM, Pavarino-Bertelli EC.

Eur J Paediatr Neurol. 2012 Jan;16(1):42-7. doi: 10.1016/j.ejpn.2011.10.002. Epub 2011 Nov 15.

PMID:
22088602
4.

Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities.

Barbier C, Chabernaud C, Barantin L, Bertrand P, Sembely C, Sirinelli D, Castelnau P, Cottier JP.

Neuroradiology. 2011 Feb;53(2):141-8. doi: 10.1007/s00234-010-0776-4. Epub 2010 Oct 20.

PMID:
20959972
5.

Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.

Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.

J Hepatol. 2013 Oct;59(4):651-7. doi: 10.1016/j.jhep.2013.05.008. Epub 2013 May 13.

PMID:
23680314
6.

Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.

Ferraz-Filho JR, da Rocha AJ, Muniz MP, Souza AS, Goloni-Bertollo EM, Pavarino-Bertelli EC.

Pediatr Radiol. 2012 Apr;42(4):449-54. doi: 10.1007/s00247-011-2274-1. Epub 2011 Oct 28.

PMID:
22033857
7.

Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?

Rodrigues AC Jr, Ferraz-Filho JR, Torres US, da Rocha AJ, Muniz MP, Souza AS, Goloni-Bertollo EM, Pavarino ÉC.

Pediatr Neurol. 2015 Mar;52(3):314-9. doi: 10.1016/j.pediatrneurol.2014.11.014. Epub 2014 Dec 1.

PMID:
25585912
8.

Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.

Tognini G, Ferrozzi F, Garlaschi G, Piazza P, Patti A, Virdis R, Bertolino C, Bertolino G, Manfredini D, Zompatori M, Crisi G.

J Comput Assist Tomogr. 2005 May-Jun;29(3):298-304.

PMID:
15891494
9.

Neurofibromatosis type 1: diffusion weighted imaging findings of brain.

Alkan A, Sigirci A, Kutlu R, Ozcan H, Erdem G, Aslan M, Ates O, Yakinci C, Egri M.

Eur J Radiol. 2005 Nov;56(2):229-34. Epub 2005 Jun 15.

PMID:
15963674
10.

In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.

Zou QG, Xu HB, Liu F, Guo W, Kong XC, Wu Y.

Clin Radiol. 2011 Oct;66(10):953-60. doi: 10.1016/j.crad.2011.05.001. Epub 2011 Jun 12.

PMID:
21663899
11.

Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.

DeBella K, Poskitt K, Szudek J, Friedman JM.

Neurology. 2000 Apr 25;54(8):1646-51.

PMID:
10762507
12.

Alterations in white matter microstructure in neurofibromatosis-1.

Karlsgodt KH, Rosser T, Lutkenhoff ES, Cannon TD, Silva A, Bearden CE.

PLoS One. 2012;7(10):e47854. doi: 10.1371/journal.pone.0047854. Epub 2012 Oct 19.

13.

Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features.

Aydin S, Kurtcan S, Alkan A, Guler S, Filiz M, Yilmaz TF, Sahin TU, Aralasmak A.

Clin Imaging. 2016 Nov - Dec;40(6):1092-1095. doi: 10.1016/j.clinimag.2016.06.013. Epub 2016 Jul 1.

PMID:
27423006
14.

A piglet model for detection of hypoxic-ischemic brain injury with magnetic resonance imaging.

Munkeby BH, De Lange C, Emblem KE, Bjørnerud A, Kro GA, Andresen J, Winther-Larssen EH, Løberg EM, Hald JK.

Acta Radiol. 2008 Nov;49(9):1049-57. doi: 10.1080/02841850802334224.

15.

Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging.

van Engelen SJ, Krab LC, Moll HA, de Goede-Bolder A, Pluijm SM, Catsman-Berrevoets CE, Elgersma Y, Lequin MH.

AJNR Am J Neuroradiol. 2008 Apr;29(4):816-22. doi: 10.3174/ajnr.A0921. Epub 2008 Mar 13.

16.

Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas.

Price SJ, Young AM, Scotton WJ, Ching J, Mohsen LA, Boonzaier NR, Lupson VC, Griffiths JR, McLean MA, Larkin TJ.

J Magn Reson Imaging. 2016 Feb;43(2):487-94. doi: 10.1002/jmri.24996. Epub 2015 Jul 3.

17.

Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.

Wang PY, Kaufmann WE, Koth CW, Denckla MB, Barker PB.

Ann Neurol. 2000 Apr;47(4):477-84.

PMID:
10762159
18.

Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.

Liu C, Jiang R, Yi X, Zhu W, Bu B.

J Neurol Sci. 2015 Jan 15;348(1-2):206-10. doi: 10.1016/j.jns.2014.12.004. Epub 2014 Dec 6.

PMID:
25524526
19.

Serial MR imaging and 1H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1.

Imamura A, Matsuo N, Okuda M, Morita H, Iwata M, Yamazaki Y, Takahashi Y.

Brain Dev. 2005 Dec;27(8):595-7.

PMID:
15878248
20.

Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1.

Zamboni SL, Loenneker T, Boltshauser E, Martin E, Il'yasov KA.

AJNR Am J Neuroradiol. 2007 Apr;28(4):773-6.

Supplemental Content

Support Center